Literature DB >> 15660281

Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.

Hajime Kuroda1, Jun-ichi Tamaru, Goi Sakamoto, Kiyoshi Ohnisi, Shinji Itoyama.   

Abstract

Medullary carcinoma (MC) of the breast is characterized by large anaplastic cells and infiltration by benign lymphocytes. Patients with this pattern of breast carcinoma are considered to have a better prognosis than those with other histological subtypes. We reviewed cases of primary breast carcinoma that were surgically resected between 1990 and 2004. Of these, 13 cases of medullary carcinoma of the breast with lymphocyte infiltration were reported. Tests for CD3, CD4, CD8, CD20, CD56, TIA-1, and granzyme B were performed on paraffin sections. We found that the MC contained very few NK cells, as assessed by their reactivity with the CD56 antibodies. However, MC had a significantly greater percentage of CD3, CD8, TIA-1, and granzyme B lymphocytes infiltrating the stroma of the tumor. Furthermore, more CD8-positive than CD4-positive T-cell lymphocytes were present within the tumor cell nests in MC, as opposed to the proportion in usual ductal carcinoma. The infiltrating cytotoxic/suppressor T cells in MC represent host resistance against cancer, and the high grading of the T-cell infiltration could explain, in part, a key mechanism controlling the good prognosis for this type of tumor and solve the pathological paradox of MC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15660281     DOI: 10.1007/s00428-004-1143-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.

Authors:  E Yakirevich; O B Izhak; G Rennert; Z G Kovacs; M B Resnick
Journal:  Mod Pathol       Date:  1999-11       Impact factor: 7.842

2.  Nodal response in medullary carcinoma of the breast.

Authors:  M Arlen; L Flores; A Elguezbal; B S Levowitz
Journal:  Am J Surg       Date:  1976-03       Impact factor: 2.565

3.  Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast.

Authors:  J Ben-Ezra; K Sheibani
Journal:  Cancer       Date:  1987-06-15       Impact factor: 6.860

4.  Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer.

Authors:  J M Hudson; A Castilleja; J L Murray; T Honda; A Kudelka; E Singletary; J T Wharton; C G Ioannides
Journal:  J Interferon Cytokine Res       Date:  1998-07       Impact factor: 2.607

5.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

6.  Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.

Authors:  D Tamiolakis; C Simopoulos; A Cheva; M Lambropoulou; A Kotini; T Jivannakis; N Papadopoulos
Journal:  Eur J Gynaecol Oncol       Date:  2002       Impact factor: 0.196

7.  The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.

Authors:  Stavros N Georgiannos; Andrew Renaut; Anthony W Goode; Michael Sheaff
Journal:  Surgery       Date:  2003-11       Impact factor: 3.982

8.  Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.

Authors:  A K Bhan; C L DesMarais
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

9.  MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.

Authors:  J F Toso; C Oei; F Oshidari; J Tartaglia; E Paoletti; H K Lyerly; S Talib; K J Weinhold
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

10.  In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.

Authors:  C Gaudin; P Y Dietrich; S Robache; M Guillard; B Escudier; M J Lacombe; A Kumar; F Triebel; A Caignard
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

View more
  16 in total

1.  Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach.

Authors:  Ramziya Kiyamova; Olga Kostianets; Sergey Malyuchik; Valeriy Filonenko; Vasiliy Usenko; Vadym Gurtovyy; Yuliya Khozayenko; Stepan Antonuk; Lloyd Old; Ivan Gout
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

2.  Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.

Authors:  Ashley Cimino-Mathews; Xiaobu Ye; Alan Meeker; Pedram Argani; Leisha A Emens
Journal:  Hum Pathol       Date:  2013-05-21       Impact factor: 3.466

3.  Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.

Authors:  Kok Haw Jonathan Lim; Premasiri Upali Telisinghe; Muhd Syafiq Abdullah; Ranjan Ramasamy
Journal:  Cancer Immun       Date:  2010-01-22

4.  Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.

Authors:  Sarah F Adams; Douglas A Levine; Mark G Cadungog; Rachel Hammond; Andrea Facciabene; Narciso Olvera; Stephen C Rubin; Jeff Boyd; Phyllis A Gimotty; George Coukos
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

5.  Prognostic Factors for Breast Cancer: an Immunomorphological Update.

Authors:  Luca Roncati; Giuseppe Barbolini; Federico Piacentini; Francesco Piscioli; Teresa Pusiol; Antonio Maiorana
Journal:  Pathol Oncol Res       Date:  2015-11-20       Impact factor: 3.201

Review 6.  An immunologic portrait of cancer.

Authors:  Maria Libera Ascierto; Valeria De Giorgi; Qiuzhen Liu; Davide Bedognetti; Tara L Spivey; Daniela Murtas; Lorenzo Uccellini; Ben D Ayotte; David F Stroncek; Lotfi Chouchane; Masoud H Manjili; Ena Wang; Francesco M Marincola
Journal:  J Transl Med       Date:  2011-08-29       Impact factor: 5.531

7.  Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.

Authors:  Raoul Droeser; Inti Zlobec; Ergin Kilic; Uwe Güth; Michael Heberer; Giulio Spagnoli; Daniel Oertli; Coya Tapia
Journal:  BMC Cancer       Date:  2012-04-03       Impact factor: 4.430

8.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

9.  Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies.

Authors:  Ilse Roodink; Kiek Verrijp; Jos Raats; William P J Leenders
Journal:  BMC Cancer       Date:  2009-08-25       Impact factor: 4.430

10.  Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients.

Authors:  Hee Jin Lee; Jin-Young Seo; Jin-Hee Ahn; Sei-Hyun Ahn; Gyungyub Gong
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.